Vascular–Apoptotic Crosstalk in Alzheimer's Disease: The Possible Role of Vascular Senescence in Blood–Brain Barrier Dysfunction
European Journal of Neurology · 2026-07 · 33 (7)
DOI: 10.1111/ene.70679 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 14.07.2026. Verfasst von Carlangelo Carrese und 8 weiteren Autor:innen. Beteiligte Einrichtung: Memory Clinic and Neurodegenerative Dementia Research Unit, University of Rome "Tor Vergata", Rome, Italy. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Apoptosis, Alzheimer Disease, Tumor Suppressor Protein p53. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Blood–brain barrier (BBB) dysfunction is an early feature of Alzheimer's disease (AD), influenced by amyloid pathology, astrocyte activation, and vasoactive mediators such as endothelin‐1 (ET‐1). ET‐1 has been implicated in apoptosis and vascular senescence through induction of p53, a pro‐apoptotic factor, whereas BCL‐X exerts antiapoptotic effects. We investigated the interplay between ET‐1, p53, and BCL‐X in AD and their contribution to BBB permeability.
Methods
We studied 101 individuals (70 AD, 31 controls) who underwent cerebrospinal fluid (CSF) analysis for Aβ42, p‐tau, ET‐1, p53, BCL‐X, and the CSF/serum albumin quotient (QAlb), an index of BBB permeability. Correlations between biomarkers were explored, followed by multiple regression and mediation analysis to assess whether p53 mediated the ET‐1–BBB relationship.
Results
No absolute differences in ET‐1, p53, or BCL‐X were found between AD and controls. However, in AD, ET‐1 correlated positively with p53 and negatively with BCL‐X, whereas no such associations were seen in controls. None of these biomarkers related to the p‐tau/Aβ42 ratio. Regression analysis identified both ET‐1 and p53 as independent predictors of BBB permeability. Mediation analysis further revealed that ET‐1 influenced BBB permeability both directly and indirectly through p53.
Conclusion
Our findings suggest that AD is characterized less by absolute biomarker changes and more by altered interrelationships linking ET‐1, apoptosis, and BBB integrity. ET‐1 may promote BBB dysfunction partly via p53, which is consistent with the mechanisms of vascular senescence. These results highlight apoptosis–vascular interactions as potential drivers of BBB impairment in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Memory Clinic and Neurodegenerative Dementia Research Unit, University of Rome "Tor Vergata", Rome, Italy.
- Neurology Unit, Policlinico Tor Vergata, University of Rome "Tor Vergata", Rome, Italy.
ORCID-Profile: Martina Gaia Di Donna, Martina Poli, Alessandro Martorana
Zitieren
APA
Carrese, C., Bonomi, C. G., Bernocchi, F., Donna, M. G. D., Poli, M., Greco, G., Mercuri, N. B., Martorana, A., & Motta, C. (2026). Vascular–Apoptotic Crosstalk in Alzheimer's Disease: The Possible Role of Vascular Senescence in Blood–Brain Barrier Dysfunction. European Journal of Neurology, 33(7). https://doi.org/10.1111/ene.70679
Vancouver
Carrese C, Bonomi CG, Bernocchi F, Donna MGD, Poli M, Greco G, et al. Vascular–Apoptotic Crosstalk in Alzheimer's Disease: The Possible Role of Vascular Senescence in Blood–Brain Barrier Dysfunction. European Journal of Neurology. 2026;33(7). doi:10.1111/ene.70679
BibTeX
@article{Carrese2026,
author = {Carrese, Carlangelo and Bonomi, Chiara Giuseppina and Bernocchi, Francesca and Donna, Martina Gaia Di and Poli, Martina and Greco, Guido and Mercuri, Nicola Biagio and Martorana, Alessandro and Motta, Caterina},
title = {Vascular–Apoptotic Crosstalk in Alzheimer's Disease: The Possible Role of Vascular Senescence in Blood–Brain Barrier Dysfunction},
journal = {European Journal of Neurology},
year = {2026},
volume = {33},
number = {7},
doi = {10.1111/ene.70679}
}
EUVIMED